![Manuel Reina](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Manuel Reina
Corporate Officer/Principal chez University of Barcelona
Postes actifs de Manuel Reina
Sociétés | Poste | Début | Fin |
---|---|---|---|
University of Barcelona | Corporate Officer/Principal | - | - |
Historique de carrière de Manuel Reina
Anciens postes connus de Manuel Reina
Sociétés | Poste | Début | Fin |
---|---|---|---|
Advancell Advanced In Vitro Cell Technologies SL
![]() Advancell Advanced In Vitro Cell Technologies SL BiotechnologyHealth Technology Advancell Advanced In Vitro Cell Technologies SL is a holding company engaged in the design, development, and testing of pharmaceutical products. It focuses on indications in the areas of oncology, dermatology, and neurology. Its pipeline consists of medications for hand-food syndrome, chronic lymphocytic leukemia, multiple sclerosis, psoriasis, and myelodysplastic syndromes. These are then licensed to affiliates for manufacturing and distribution. The company was founded by Susana Castel-Gil, Senen Vilar, and Manuel Reina in 2001, and is headquartered in Barcelona, Spain. | Directeur/Membre du Conseil | - | - |
Formation de Manuel Reina
Consejo Superior de Investigaciones Científicas | Doctorate Degree |
Statistiques
Internationale
Espagne | 4 |
Opérationnelle
Director/Board Member | 1 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Advancell Advanced In Vitro Cell Technologies SL
![]() Advancell Advanced In Vitro Cell Technologies SL BiotechnologyHealth Technology Advancell Advanced In Vitro Cell Technologies SL is a holding company engaged in the design, development, and testing of pharmaceutical products. It focuses on indications in the areas of oncology, dermatology, and neurology. Its pipeline consists of medications for hand-food syndrome, chronic lymphocytic leukemia, multiple sclerosis, psoriasis, and myelodysplastic syndromes. These are then licensed to affiliates for manufacturing and distribution. The company was founded by Susana Castel-Gil, Senen Vilar, and Manuel Reina in 2001, and is headquartered in Barcelona, Spain. | Health Technology |
- Bourse
- Insiders
- Manuel Reina
- Expérience